Delavirdine Production Cost Reports

The report provides a detailed analysis essential for establishing a Delavirdine production plant. It encompasses all critical aspects necessary for Delavirdine production, including the cost of Delavirdine production, Delavirdine plant cost, Delavirdine production costs, and the overall Delavirdine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Delavirdine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Delavirdine is an antiretroviral drug used for the treatment of human immunodeficiency virus (HIV) type 1 infection. It belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs), which block the activity of HIV reverse transcriptase, an enzyme essential for viral replication. Its main industrial application is in pharmaceutical production as an active pharmaceutical ingredient (API) in oral antiretroviral formulations, such as tablets and capsules, used in highly active antiretroviral therapy (HAART) regimens.

The market demand for Delavirdine is driven by the increasing global prevalence of HIV/AIDS, which sustains the demand for effective antiretroviral therapies (ART). Advancements in ART, leading to more effective, convenient treatment regimens such as long-acting injectables and combination therapies, improve patient adherence and outcomes further boosting the market demand.

Expanding government and NGO initiatives increases access to HIV treatment, mainly in low- and middle-income countries, which elevates the market demand. Growing awareness and screening programs lead to earlier diagnoses and treatment initiation, fuelling demand. The availability of generic HIV drugs that enhance affordability and broaden therapy coverage contributes to the market growth. Additionally, funding from government health budgets, international donors, and public-private partnerships determines industrial delavirdine procurement volumes and frequency. The presence of generic alternatives and competition from newer drug classes affects the demand and procurement priorities for Delavirdine. Delavirdine’s clinical profile, such as known drug interactions and declining use in some regions, further influences buyer preference and procurement volumes.

Raw Material for Delavirdine Production

According to the Delavirdine production plant project report, the various raw materials for Delavirdine production include piperazine- chloropyridine.

Production Process of Delavirdine

The extensive Delavirdine production cost report consists of the following major industrial production process:

1. Production via chemical synthesis: The production process of Delavirdine begins with the reaction of piperazine with chloropyridine to form a nitro-substituted intermediate, which is reduced to an amine. This amine undergoes reductive amination with acetone to yield pyridylpiperazine. In the next step, coupling this intermediate with 6-nitroindole-2-carboxylic acid using coupling agents like EDC or CDI forms an amide. The nitro group in the amide is then reduced by catalytic hydrogenation to an amine, which is subsequently sulfonylated with methanesulfonyl chloride to produce Delavirdine.

Properties of Delavirdine

Delavirdine is a white to tan crystalline powder with a molecular formula of C22H28N6O3S and a molecular weight of 456.57 g/mol. It is an odourless solid with a melting point range of 226-228 degree Celsius. The compound exhibits low solubility in water and ethanol but is more soluble in DMSO. It contains functional groups such as an N-acylpiperazine, sulfonamide, aminopyridine, and indolecarboxamide. It has three hydrogen bond donors and six hydrogen bond acceptors, with a logP (octanol-water partition coefficient) around 2.7 to 2.8, indicating moderate lipophilicity. Its topological polar surface area (TPSA) is about 110-114 Ų, which influences its absorption and cell permeability. Delavirdine acts by binding to the HIV-1 reverse transcriptase enzyme, causing a conformational change that inhibits viral replication. It is stable under typical storage conditions (-20 degree Celsius recommended) and is used as the mesylate salt in pharmaceutical formulations.